跳至主要内容
临床试验/NCT03189667
NCT03189667终止不适用

Drug Coated Balloons vs Plain Balloons for the Management of Dysfunctional Dialysis Fistula

King Abdullah International Medical Research Center2 个研究点 分布在 1 个国家目标入组 23 人开始时间: 2017年10月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
入组人数
23
试验地点
2
主要终点
AVF circuit patency

研究概览

简要总结

Compare the effectiveness of drug-coated balloons to plain balloon angioplasty in reducing stenosis rates in dialysis arteriovenous fistulas (AVFs).

详细描述

Objectives of the Study:

Hypothesis: Drug-coated balloons improve functional and patency outcomes of failing/dysfunctional hemodialysis fistulas compared to plain uncoated balloons

Aim of the Study:

Compare the effectiveness of drug-coated balloons to plain balloon angioplasty in reducing stenosis rates in dialysis AVFs.

Specific Objectives:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Inclusion criteria
  • >18 year old
  • Dysfunctional dialysis fistula
  • Radiocephalic
  • Brachiocephalic
  • Brachiobasilic
  • Clinical criteria for diagnosis of dysfunctional fistula:
  • Swelling of the fistula limb
  • Prolonged bleeding after withdrawing access needles
  • Abnormal pulsations or weak thrill.
  • Functional criteria for the diagnosis of dysfunctional criteria:
  • Arteriovenous fistula is unable to deliver dialysis blood flow (Qb) of equal to or more than 300 ml/min and/or access recirculation of more than 10% on at least two occasions,
  • A rising trend of venous pressure or excessive negative arterial pressure, and/or unable to deliver a Kt/v of 1.2 or more.
  • Non-thrombosed

排除标准

  • Dysfunctional arteriovenous (AV) grafts
  • Thrombosed fistulas
  • Intra-stent stenosis
  • Stenoses not responding to balloon angioplasty and requiring stenting.
  • Stenosis less than 50%
  • Surgical intervention that excludes the treatment segment from the access circuit
  • Systemic or local (to the fistula) infection treated for less than 10 days prior to the study procedure
  • Location of isolated stenosis central to the thoracic inlet.
  • Women who are breastfeeding, pregnant or are intending to become pregnant
  • Known hypersensitivity or contraindication to contrast medium which cannot be adequately premeditated.
  • Sensitivities to heparin, aspirin, other anticoagulant/antiplatelet therapies, and/or paclitaxel

研究组 & 干预措施

Drug coated balloon angioplasty

Experimental
  • Vessel preparation with Pre dilatation
  • Vessel treatment with Drug-coated balloon

干预措施: Vessel preparation with angioplasty (Device)

Drug coated balloon angioplasty

Experimental
  • Vessel preparation with Pre dilatation
  • Vessel treatment with Drug-coated balloon

干预措施: Drug coated balloon angioplasty (Device)

Plain balloon angioplasty

Active Comparator
  • Vessel preparation with Pre dilatation
  • Vessel treatment with additional Plain balloon angioplasty:

干预措施: Vessel preparation with angioplasty (Device)

Plain balloon angioplasty

Active Comparator
  • Vessel preparation with Pre dilatation
  • Vessel treatment with additional Plain balloon angioplasty:

干预措施: Plain balloon angioplasty (Device)

结局指标

主要结局

AVF circuit patency

时间窗: 12 month

Dialysis adequacy to be assessed based on functional criteria

次要结局

  • Technical success(intra procedural)
  • Target lesion restenosis free survival(12 month)
  • Access circuit dysfunction free survival(12 month)
  • Number of participants with treatment-related adverse events(12 month following the procedure)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验